Apraclonidine Hcl 0.5% Oph Soln ( DrugBank: Apraclonidine )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
11	重症筋無力症	1

11. 重症筋無力症

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05045248 (ClinicalTrials.gov)	June 1, 2020	29/8/2021	Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis	Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis	Myasthenia Gravis;Ocular Myasthenia Gravis	Drug: Apraclonidine Hcl 0.5% Oph Soln	American University of Beirut Medical Center	NULL	Completed	18 Years	N/A	All	10	Phase 2	Lebanon

First Previous1Next Last